Lawrence J. Green, MD, FAAD

NPF Endorsed Features

Update on Oral Molecules

09/24/2018

Lawrence J. Green , MD, FAAD;

This article discusses the latest evidence on oral molecules for the treatment of psoriasis and psoriatic arthritis.

This article discusses the...

09/24/2018

The Dermatologist

Coding Changes in 2022

03/10/2022

Lawrence J. Green , MD, FAAD;

In this exclusive interview, Board Member Lawrence Green, MD, and American Academy of Dermatology President-Elect Mark Kaufmann, MD, discuss recent billing coding changes and what dermatologists need to know about the changes in 2022.

In this exclusive interview,...

03/10/2022

The Dermatologist

Cover Story

Establishing a Clinical Trials Practice

02/07/2023

Lawrence J. Green , MD, FAAD;

Have you found yourself thinking, “I am interested in running a clinical trial, now what?” Dr Lawrence J. Green answers key questions to get you started on the road to conducting clinical trials in the office.

Have you found yourself...

02/07/2023

The Dermatologist

Advances in Psoriasis Therapies

08/13/2020

Lawrence J. Green , MD, FAAD;

The psoriasis treatment landscape keeps changing for the better, with newer injectable and topical therapies available for patients with mild, moderate, and severe disease. Within the past 2 years alone, the FDA...

...

08/13/2020

The Dermatologist

The Maze of Managed Care

10/03/2017

Lawrence J. Green , MD, FAAD;

In the current managed care environment, it is harder for dermatologists to place their patients on what they feel is the best choice medication for each patient.

In the current managed care...

10/03/2017

The Dermatologist

Commentary

Commentary: Unnecessary Burden of Step Therapy

08/23/2019

Lawrence J. Green , MD, FAAD;

Lawrence Green, MD, shares his perspective on a recent article that showed step therapy and prior authorizations negatively impacted patient care and treatment adherence.

Lawrence Green, MD, shares his...

08/23/2019

The Dermatologist